A manufacturing company has a wide range of businesses including analytical instruments, medical devices, and industrial equipment. Recently, the company has been focusing on healthcare, specifically in clinical diagnostics and biomanufacturing. In April 2023, the company established a CVC (corporate venture capital) department and is looking for strategic partnerships with companies with cutting-edge technology that align with their businesses. The fund will be managed for 10 years with a total investment of $50M USD. So far, the venture arm has invested in 3 companies in the U.S. and Japan and is looking to expand their investments in the States, though they are open to meeting with global companies. The fund is looking to invest in Pre-Seed to Early rounds but may invest as far as Series A. Typical check size can range from $1-10M USD but can exceed if there is a particularly strong interest in a technology.
In terms of healthcare, the venture arm is looking to invest in clinical diagnostics, medical devices, and biomanufacturing. The firm is open to not only hardware but consumables as well.
To attract investment from the venture arm, having a lead investor is desirable.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment